This application requests continued support for 6 trainees for a Predoctoral Training Program (TP) in Biotechnology that was first funded in 1990. If granted, these 6 lines will be matched by 6 more lines by the University of Iowa, through its Center for Biocatalysis and Bioprocessing (CBB). The CBB will also continue to provide the administrative and additional financial. This institutional match will allow the TP to select a yearly cohort of 12 predoctoral students. The CBB will also provide administrative assistance and training in industrial settings and will expose trainees to commercial aspects of biotechnology. This matching support will greatly increases the effectiveness of the funds requested from NIH and assures an extensive industrial emphasis in training. The TP is designed to provide a deep and diverse education to trainees, including academic training covering qualitative and quantitative aspects of biotechnology, hands- on introduction to industrial methods, and preparation for professional life in biotechnology. Trainees are required to: a) complete an industrial internship for three months; b) take at least one course in each of the three core areas of biotechnology (Biocatalysis, Bioreactors & Bioseparations, Molecular Biology & Genetics); c) take the program's capstone course, ?Introduction to Biocatalysis?; d) take a course in Responsible Conduct of Research; e) participate in the ?Perspectives in Biocatalysis? class and activities every semester; f) participate in TP's Seminars; g) present research in an annual Biocatalysis and Bioprocessing Conference and the annual TP symposium; and h) participate in various trainee-cohort social and networking activities. Candidates are selected toward the end of their first year in graduate school, and support for trainees may be renewed for up to two years, however all trainees continue in the program until graduation. The recruiting pool is based not on departmental affiliation but on interest in biotechnology, graduate training. Currently 33 trainers from four different colleges, and two interdisciplinary PhD programs participate in this TP. The diverse trainers cohort, together with the CBB partnership, provides trainees with a broad training experience including significant exposure to non-academic career paths. The TP is administered by a Leadership Team (a PI and three Co-PIs) and an Executive Committee. An External Review Panel provides independent input to assure relevance to the leadership and training needs of Biotech industry and research.

Public Health Relevance

Participating faculty laboratories provide trainees with a wide range of research opportunities in the biomedical sciences. Among these are investigations of environmentally-friendly biocatalytic processes for chemical transformations, development of new antibiotics, synthesis and evaluation of new anticancer chemotherapeutics, and new approaches to drug and gene delivery. Training Program coursework enhances trainee understanding of biomedical and bioengineering sciences, and provides guidance in the ethical conduct of research.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM008365-29
Application #
9965995
Study Section
NIGMS Initial Review Group (TWD)
Program Officer
Brown, Patrick
Project Start
1990-07-01
Project End
2022-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
29
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Iowa
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Ricker, Erica B; Aljaafari, Haydar A S; Bader, Trigg M et al. (2018) Thermal shock susceptibility and regrowth of Pseudomonas aeruginosa biofilms. Int J Hyperthermia 34:168-176
Mondal, Dibyendu; Koehn, Eric M; Yao, Jiajun et al. (2018) Chemo-enzymatic synthesis of the exocyclic olefin isomer of thymidine monophosphate. Bioorg Med Chem 26:2365-2371
Oppegard, Lisa M; Delgado, Justine L; Kulkarni, Chaitanya A et al. (2018) Novel N-1 substituted fluoroquinolones inhibit human topoisomerase I activity and exhibit anti-proliferative activity. Invest New Drugs :
Imai, Yumi; Fink, Brian D; Promes, Joseph A et al. (2018) Effect of a mitochondrial-targeted coenzyme Q analog on pancreatic ?-cell function and energetics in high fat fed obese mice. Pharmacol Res Perspect 6:e00393
Delgado, Justine L; Hsieh, Chao-Ming; Chan, Nei-Li et al. (2018) Topoisomerases as anticancer targets. Biochem J 475:373-398
Towle, Tyrell R; Kulkarni, Chaitanya A; Oppegard, Lisa M et al. (2018) Design, synthesis, and evaluation of novel N-1 fluoroquinolone derivatives: Probing for binding contact with the active site tyrosine of gyrase. Bioorg Med Chem Lett 28:1903-1910
Bain, Fletcher E; Fischer, Laura A; Chen, Ran et al. (2018) Single-Molecule Analysis of Replication Protein A-DNA Interactions. Methods Enzymol 600:439-461
Vanle, Brigitte C; Florang, Virginia R; Murry, Daryl J et al. (2017) Inactivation of glyceraldehyde-3-phosphate dehydrogenase by the dopamine metabolite, 3,4-dihydroxyphenylacetaldehyde. Biochem Biophys Res Commun 492:275-281
Stockdale, David P; Titunick, Michelle B; Biegler, Jessica M et al. (2017) Selective opioid growth factor receptor antagonists based on a stilbene isostere. Bioorg Med Chem 25:4464-4474
Wills, Veronica S; Metzger, Joseph I; Allen, Cheryl et al. (2017) Bishomoisoprenoid triazole bisphosphonates as inhibitors of geranylgeranyl diphosphate synthase. Bioorg Med Chem 25:2437-2444

Showing the most recent 10 out of 128 publications